La Roche and Spark announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement.
Featured News
CRA Expands Antitrust Expertise with Senior Economist Appointment
Jul 13, 2025 by
CPI
Disney’s Proposed Antitrust Settlement Triggers Clash Among Plaintiffs’ Law Firms
Jul 13, 2025 by
CPI
Brazilian Antitrust Authority Greenlights Goodyear Chemical Unit Sale
Jul 13, 2025 by
CPI
DOJ Greenlights T-Mobile’s Purchase of US Cellular Assets Despite Market Concentration Concerns
Jul 13, 2025 by
CPI
Judge Rejects Novartis Bid to Delay Entresto Generic
Jul 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Surveillance Pricing
Jul 14, 2025 by
CPI
Should We Fear Personalized Pricing?
Jul 14, 2025 by
John Yun
Data and Price Competition: The Special Role of Information About Rivals’ Prices
Jul 14, 2025 by
Zach Y. Brown & Alexander MacKay
Surveillance Pricing: A Cautionary Summary of Potential Harms and Solutions
Jul 14, 2025 by
Ginger Zhe Jin, Liam Wagman & Mengyi Zhong
The Rise of Surveillance Pricing
Jul 14, 2025 by
Rebecca Kirk Fair, Alvaro Ziadi & Juan Carvajal